Middle East and Africa Swine Vaccines Market: By Vaccine Type, By Disease Type, By Distribution Channel, and Country Forecast 2020-2031

download arrow download arrow Download Sample
settings arrow settings arrow email us

Middle East and Africa Swine Vaccines Market: By Vaccine Type (Inactivated Vaccines, Recombinant vaccines, Live attenuated vaccines, DNA vaccines, Subunit vaccines, Others), By Disease Type (Viral Infections, Bacterial Infections, Parasitic Infection, Fungal Infections, Others), By Distribution Channel (Veterinary Hospitals, Veterinary Pharmacies, Online Pharmacies), and Country Forecast 2020-2031

checked icon checked icon arrow_drop_down
checked icon Single User License $3100 $2480
checked icon Multiple User License $4600 $3680
checked icon Corporate User License $6900 $5520

Middle East And Africa Swine Vaccines Market size was valued at US$ X million in 2024 and is expected to reach US$ X million by 2031, growing at a significant CAGR of X% from 2025-2031. are the biological preparations that provide acquired immunity to the particular disease. Vaccine typically contains the agent that resembles a disease-causing microorganism and made from the killed or weakened forms of microbe, its surface proteins, or toxins. Swine vaccines are manufactured for the prevention or cure of various diseases in swine. Most commonly occurred diseases in swine include parasitic diseases, foodborne diseases, and infectious diseases among others. These vaccines prevent the diseases and make the swine healthy.

Middle East And Africa Swine Vaccines Market

Drivers

  • High demand for healthy pork meat and rise in pork meat production
  • Rise in prevalence of various infectious and foodborne diseases and expansion of business by the market players
  • Grow in adoption of newer vaccines and development in economic growth

Restraints

  • Stringent regulatory policies for the swine vaccine approval
  • Adverse effects such as allergies associated with the vaccines
  • High cost of vaccines and lack of awareness about the swine diseases in underdeveloped countries

Middle East And Africa Swine Vaccines Market Segmentation Analysis

Report Benchmarks

Details

By Vaccine type

  • Inactivated Vaccines
  • Recombinant vaccines
  • Live attenuated vaccines
  • DNA vaccines
  • Subunit vaccines
  • Others

By Disease type

  • Viral Infections
  • Bacterial Infections
  • Parasitic Infection
  • Fungal Infections
  • Others

By Distribution channel

  • Veterinary Hospitals
  • Veterinary Pharmacies
  • Online Pharmacies

country

  • Gulf Cooperation Council (GCC) Countries
  • Israel
  • South Africa
  • Rest of MEA

Key Features of the Report

  • The middle east and africa swine vaccines Market report provides granular level information about the market size, regional market share, historic market (2020-2024), and forecast (2025-2031)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis

Download Free Sample Report

I accept the Terms and Conditions,Disclaimers, GDPR Policy

Frequently Asked Questions

Middle east and africa swine vaccines market size was valued at US$ X million in 2024 and is expected to reach US$ X million by 2031, growing at a significant CAGR of X%.

The market data: Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

The market key players are Zoetis (Pfizer, Inc.) (U.S.), Merck & Co. Inc. (U.S), Virbac S.A. (France), Boehringer Ingelheim Vetmedica (Germany), Elanco (U.S.), Bayer Animal Health (Germany), Ceva Sante Animale (France)

Author image

Author

Manoj Kumar

Manoj Kumar is a postgraduate in Life Sciences with over seven years of dedicated experience in the fields of anima.....

1.Executive Summary
2. Middle East And Africa Swine Vaccines Market Introduction 
2.1. Middle East And Africa Swine Vaccines Market  - Taxonomy
2.2. Middle East And Africa Swine Vaccines Market  - Definitions
2.2.1.Vaccine type
2.2.2.Disease type
2.2.3.Distribution channel
2.2.4.country
3. Middle East And Africa Swine Vaccines Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4. Middle East And Africa Swine Vaccines Market Analysis, 2020 - 2024 and Forecast 2025 - 2031
4.1.  Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5. Middle East And Africa Swine Vaccines Market  By Vaccine type, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
5.1. Inactivated Vaccines
5.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Recombinant vaccines
5.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Live attenuated vaccines
5.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. DNA vaccines
5.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
5.5. Subunit vaccines
5.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.5.3. Market Opportunity Analysis 
5.6. Others
5.6.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.6.3. Market Opportunity Analysis 
6. Middle East And Africa Swine Vaccines Market  By Disease type, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
6.1. Viral Infections
6.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Bacterial Infections
6.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Parasitic Infection
6.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Fungal Infections
6.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
6.5. Others
6.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.5.3. Market Opportunity Analysis 
7. Middle East And Africa Swine Vaccines Market  By Distribution channel, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
7.1. Veterinary Hospitals
7.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Veterinary Pharmacies
7.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Online Pharmacies
7.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
8. Middle East And Africa Swine Vaccines Market  By country, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
8.1. Middle East and Africa (MEA)
8.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. GCC Countries
8.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. South Africa
8.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Rest of MEA
8.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
9. Competition Landscape
9.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
9.2.1.Zoetis (Pfizer, Inc.) (U.S.)
9.2.2.Merck & Co. Inc. (U.S)
9.2.3.Virbac S.A. (France)
9.2.4.Boehringer Ingelheim Vetmedica (Germany)
9.2.5.Elanco (U.S.)
9.2.6.Bayer Animal Health (Germany)
9.2.7.Ceva Sante Animale (France)
10. Research Methodology 
11. Appendix and Abbreviations 

Key Market Players

  • Zoetis (Pfizer, Inc.) (U.S.)
  • Merck & Co. Inc. (U.S)
  • Virbac S.A. (France)
  • Boehringer Ingelheim Vetmedica (Germany)
  • Elanco (U.S.)
  • Bayer Animal Health (Germany)
  • Ceva Sante Animale (France)

Related Industry Reports

Feed Probiotics Market

Animal Microbiome Market

Veterinary Oncology Market

Pet Herbal Supplement Market